$ 25.70

NR 503 EPIDEMIOLOGY FINAL EXAM REAL QUESTIONS AND 100% COMPLETE AND CORRECT ANSWERS AND EXPLANATION/GRADED A2023 VERSION

NR 503 EPIDEMIOLOGY FINAL EXAM REAL QUESTIONS AND 100% COMPLETE AND CORRECT ANSWERS AND EXPLANATION/GRADED A2023 VERSION

Question 1
Which of the following statements best describe efficacy?
• It is an estimate of the benefit of treatment under ideal conditions
• It is an estimate of the benefit of treatment under routine conditions


It is an estimate of the reduction of disease in treated groups
It is an estimate of the reduction of disease in the population
• It depends on the prevalence of disease


study is conducted for a pharmaceutical agent that has shown promise for reducing
heart disease among women. In order to more fully test the agent, an additional study is
done restricting the participants to be randomized to those who have a history of
hypertension. Which of the following advantages cannot be claimed by the researchers?
• Power of the study is increased
• Potential benefits in high-risk populations are increased
• Validity of the study is increased by focus on a homogenous population
• The generalizability of the study is increased
• The overall cost of the study is decreased
Restricting the study to a high-risk group will only fail to increase the
generalizability of the findings since the study results will apply only to a more
specific group of women who share a history of hypertension.
Question 3
A new drug treatment for cardiac thrombus claims to have a higher success rate than
the current drug. A strong sign of the potential success is the lack of internal
hemorrhaging starting 2 days after treatment. 168 patients who require treatment for
cardiac thrombi are randomized after agreeing to participate in a trial of the new drug.
The researchers were interested in whether the new drug reduced the need for blood
transfusions due to internal hemorrhage compared to the current treatment. The
following table summarizes the results of her study:
What is the incidence of needing a blood transfusion in the group of persons who were
randomized to the new drug treatment?
• 31.0%
• 41.1%
Incidence is the development of the outcome under investigation among those
at risk. In this instance, 43 participants “developed” the need for a blood

Preview document (3 of 63 pages)

Unlock document

Download all 63 pages for $ 25.70

Add document to cart
Report document Report document

Knoowy benefits

$ 25.70

Add document to cart
  • check Money back guarantee
  • check Documents can be downloaded immediately
  • check $0.50 discount when paying with balance
  • check Receive free quiz questions with document

Specifications

Seller

Scholar Master

442 documents uploaded

45 documents sold

1 services offered


Hello and welcome to Scholar Master! I'm thrilled to have you here. At Scholar Master, I offer top-tier academic assistance and tutoring for various assignments, quizzes, and examinations, with a guaranteed A+ outcome.

Specializing in key subjects such as psychology, nursing, human resource management, and mathematics, my foremost commitment is delivering top-notch quality to students. I uphold rigorous scholarly standards in all my work, earning recognition as one of the premier gold-rated tutors on Knoowy.

Trust in Scholar Master's services for a superior grade assurance and let’s work together to make your academic goals a reality. Thank you for choosing Scholar Master. I look forward to helping you succeed!

Earn from your summaries?

icon 2

Do you make summaries or do you have any completed assignments? Upload your documents to Knoowy and earn money.

Upload document
Log in via e-mail
New password
Subscribe via e-mail
Shopping cart

Deal: get 10% off when you purchase 3 or more items!

Deal: get 10% off when you purchase 3 or more items!

[Inviter] gives you € 2.50 to purchase summaries

At Knoowy you buy and sell the best studies documents directly from students. <br> Upload at least one item, please help other students and get € 2.50 credit.

Register now and claim your credit